GHK-Cu and propolis may help prevent scalp aging and hair loss.
5 citations
,
May 2024 in “Journal of Allergy and Clinical Immunology Global” Upadacitinib effectively improved severe atopic dermatitis and alopecia universalis in a 29-year-old man.
March 2009 in “Hair transplant forum international” The document's conclusion cannot be provided because the content is not accessible.
July 2013 in “Hair transplant forum international” The document's content cannot be summarized because it is not accessible or understandable.
505 citations
,
October 2011 in “Journal of clinical oncology” MK-2206 was safe and effectively blocked AKT signaling in cancer patients, warranting more trials.
August 2025 in “Animal nutrition” α-Ketoglutaric acid improves hair growth, rabbit performance, and antioxidant levels.
September 1997 in “Hair transplant forum international” The document's conclusion cannot be summarized because the content is not accessible.
July 1996 in “Hair transplant forum international” 20 citations
,
October 2005 in “Archives of Dermatological Research”
2 citations
,
July 2023 in “JAAD Case Reports” A woman with a type of hair loss saw hair regrowth after two months of taking baricitinib.
July 1997 in “Hair transplant forum international” I'm sorry, but there's no specific conclusion provided for me to summarize.
4 citations
,
April 2025 in “Antioxidants” Alpha-ketoglutarate protects rabbit skin cells from oxidative damage by activating a specific cell pathway.
July 2004 in “Hair transplant forum international” The document's conclusion cannot be summarized because the content is not accessible or understandable.
July 2026 in “Journal of the American Academy of Dermatology”
April 2024 in “Dermatovenerologiâ, kosmetologiâ” Actinic keratosis is a sun-induced skin condition that can potentially turn into skin cancer and requires various treatments to prevent this.
June 2025 in “British Journal of Dermatology” Irish dermatologists urgently need guidelines for using JAK inhibitors in treating alopecia areata.
July 1998 in “Hair transplant forum international” The conclusion about the value of ABHRS certification cannot be determined from the text provided.
2 citations
,
January 2019 in “Annals of Dermatology” Certain gene variations in EGF and EGFR may increase the risk of alopecia areata in Koreans.
September 2015 in “International Society of Hair Restoration Surgery” September 2017 in “The journal of investigative dermatology. Symposium proceedings/The Journal of investigative dermatology symposium proceedings” CCCA and lichen planopilaris have similar histological features, making them hard to distinguish.
March 1999 in “Hair transplant forum international” The American Board of Hair Restoration Surgery is a certification for doctors specializing in hair restoration procedures.
July 2000 in “Hair transplant forum international” The document's conclusion cannot be provided because the content is not accessible.
September 1998 in “Hair transplant forum international” The document's content could not be processed.
23 citations
,
June 2010 in “Journal of Investigative Dermatology” A mutation in the Soat1 gene causes hair structure defects and other health issues in AKR/J mice.
February 2025 in “PubMed” CS12192 effectively treats alopecia areata with better safety than current options.
Alpha-ketoglutaric acid may help treat aging and age-related diseases.
May 2015 in “Hair transplant forum international” The American Society of Hair Restoration Surgery (ASHRS) is a group focused on improving hair restoration methods.
2 citations
,
June 2012 in “PubMed” The document concludes that central centrifugal cicatricial alopecia (CCCA) should be considered in African American men with vertex hair loss and scalp symptoms, and that prompt diagnosis and treatment can slow disease progression.
August 2023 in “JAAD international” Most patients with Central Centrifugal Cicatricial Alopecia at the reviewed institution were middle-aged Black women, often with no symptoms, and commonly treated with topical medications.
June 2020 in “Dermatologic therapy” Using Janus kinase inhibitors (JAKi) in COVID-19 treatment requires careful consideration due to their immunosuppressive effects.